Let’s be clear about what exists. One is a documented investigational titration schedule. The other is community practice — a protocol people have gradually developed without any validation. They are not the same thing.
Trial schedules
Phase II trials tested weekly doses of 1, 4, 8, and 12 mg. Phase III trials narrowed the range to 4, 9, and 12 mg. All regimens start low and escalate: in TRIUMPH-1, participants started at 2 mg weekly and increased every four weeks until reaching their assigned dose.
The importance of dose escalation goes beyond appearance. In the Phase II obesity trial, two dose groups were tested twice, once starting at 2 mg and once at 4 mg. The lower starting dose partially reduced gastrointestinal side effects. The speed of escalation affects tolerability independent of the dose itself.
Community reports
Compared with clinical trials, community protocols are more conservative. Commonly reported starting doses are 0.5 to 1 mg once weekly, maintained for three to four weeks before gradual increases. Most people report capping at 4 to 8 mg, rather than the 12 mg maximum used in trials.
A 2026 preprint analyzed self-reported side effects from 13,589 Reddit users taking unapproved retatrutide. The study was not peer-reviewed and only counted what users wrote, not what they actually injected. But it is currently the only large dataset on community use.
This is not advice
To be clear, the above is not advice. It simply describes what people are doing outside clinical trials, in the absence of any other validated protocol.
Reconstitution math
Gray-market retatrutide is typically sold as 10 mg, 20 mg, or 30 mg lyophilized powder. Final concentration is vial size divided by the volume of bacteriostatic water added.
Vial BAC water added Concentration 1 mg on U-100 syringe
10 mg 2 mL 5 mg/mL 0.2 mL = 20 units
20 mg 2 mL 10 mg/mL 0.1 mL = 10 units
30 mg 3 mL 10 mg/mL 0.1 mL = 10 units
At 10 mg/mL, a 2 mg dose is 20 units, and a 4 mg dose is 40 units. Use a reconstitution calculator and dose calculator to verify your own vial and water volume rather than relying on a table alone.
Two handling cautions
Multi-dose vials should be discarded 28 days after first puncture, regardless of seller instructions. If a injectable arrives too warm, it should not be used.
Conclusion
There is a clear gap between trial dosing and community dosing. Adjusting doses without a validated protocol significantly amplifies risk.